Sinotherapeutics (SH:688247) Zheng Quan Zhi Xing·2025-08-22 16:12Core Viewpoint - The company announced its profit distribution plan for the first half of 2025, proposing a cash dividend of 0.25 RMB per 10 shares, which reflects 24.62% of the net profit attributable to shareholders for the same period [1][2]. Summary by Sections Profit Distribution Plan - The company achieved a net profit of 45,585,665.46 RMB for the first half of 2025, with distributable profits amounting to 233,727,454.95 RMB as of June 30, 2025 [1]. - The proposed cash dividend totals 11,225,097.28 RMB (including tax), based on a total share capital of 453,340,000 shares, adjusted for 4,336,109 shares held in the repurchase account [2]. - The distribution will not involve capital reserve transfers or stock dividends [2][4]. Decision-Making Process - The audit committee of the board convened on August 19, 2025, to review and approve the profit distribution proposal, which was subsequently approved by the board on August 21, 2025 [2][3].